Science Explorer Back to mapMap

Most cited papers from Vifor Pharma (Switzerland)

What are the most cited papers from Vifor Pharma (Switzerland)?

The most cited paper from Vifor Pharma (Switzerland) is "Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency" (Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al., 2009), with 2,090 citations. Next come "Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency" (1,245) and "Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial" (797).

Showing 50 of 60 papers. Every paper with more than 107 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al. · New England Journal of Medicine Open access 17 Nov 2009 2,090
2 Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Piotr P. Ponikowski, Dirk J. van Veldhuisen, Josep Comín‐Colet et al. · European Heart Journal Open access 31 Aug 2014 1,245
3 Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial Piotr P. Ponikowski et al. · The Lancet Open access210 authors 13 Nov 2020 797
4 Nanomedicines: addressing the scientific and regulatory gap Sally S. Tinkle, Scott E. McNeil, Stefan Mühlebach et al. · Annals of the New York Academy of Sciences 27 Mar 2014 541
5 Azole Fungicides: Occurrence and Fate in Wastewater and Surface Waters Maren Kahle, Ignaz J. Buerge, Andrea Hauser et al. · Environmental Science & Technology 27 Aug 2008 457
6 Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis Stefan D. Anker, Bridget‐Anne Kirwan, Dirk J. van Veldhuisen et al. · European Journal of Heart Failure ReviewOpen access 24 Apr 2017 410
7 The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress Taija Koskenkorva, Günter Weiß, Willem Hendrik Koppenol et al. · Free Radical Biology and Medicine 12 Sep 2013 410
8 The Electroantennographic Detector — a Selective and Sensitive Tool in the Gas Chromatographic Analysis of Insect Pheromones Heinrich Arn, Erich Städler, Stefan Rauscher · Zeitschrift für Naturforschung C Open access Dec 1975 376
9 FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease Rayko Evstatiev, Philippe R. Marteau, Tariq H Iqbal et al. · Gastroenterology Open access 25 Jun 2011 368
10 FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia Iain C. Macdougall, A. Böck, Fernando Carrera et al. · Nephrology Dialysis Transplantation Open access 2 Jun 2014 333
11 Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey Ian Stewart Fraser, Diana Mansour, Christian Breymann et al. · International Journal of Gynecology & Obstetrics Dec 2014 304
12 Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial Javed Butler et al. · European Heart Journal Open access 28 Jul 2022 236
13 The Pharmacokinetics and Pharmacodynamics of Iron Preparations Peter Geisser, Susanna Burckhardt · Pharmaceutics Open access 4 Jan 2011 232
14 Big data from electronic health records for early and late translational cardiovascular research: challenges and potential Harry Hemingway, Folkert Wouter Asselbergs, John Danesh et al. · European Heart Journal Open access 9 Aug 2017 217
15 Photostabilization of Butyl methoxydibenzoylmethane (Avobenzone) and Ethylhexyl methoxycinnamate by Bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), a New UV Broadband Filter¶ Eric Chatelain, Bernard Gabard · Photochemistry and Photobiology 2001 209
16 Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT) Florian Wagenlehner, Björn Wullt, Stefania Ballarini et al. · Expert Review of Pharmacoeconomics & Outcomes Research 24 Jul 2017 205
17 Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum Markus W. Wendeler, Jean‐Pierre Paccaud, Hans‐Peter Hauri · EMBO Reports Open access 26 Jan 2007 203
18 Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach? Stefan Mühlebach · Advanced Drug Delivery Reviews ReviewOpen access Jun 2018 197
19 Design of multivalent complexes using the barnase·barstar module Sergey Mikhailovich Deyev, Robert Waibel, Ekaterina N. Lebedenko et al. · Nature Biotechnology 23 Nov 2003 192
20 Essential Role of Patient Blood Management in a Pandemic: A Call for Action Aryeh Shander et al. · Anesthesia & Analgesia Open access 31 Mar 2020 191
21 Guideline for the Dosage of Neuroleptics. I MARIE-JOSÈPHE REY, Pierre Schulz, Claudine Costa et al. · International Clinical Psychopharmacology Apr 1989 191
22 A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients Jürgen Floege, Adrian Constantin Covic, Markus Ketteler et al. · Kidney International Open access 19 Mar 2014 189
23 The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study Josep Comín‐Colet, Mitja Lainščak, Kenneth Dickstein et al. · European Heart Journal Open access 31 Jan 2012 172
24 Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction Burkert Mathias Pieske et al. · JAMA Open access436 authors 16 Nov 2021 167
25 Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients Nidhi Sukul, Angelo Karaboyas, Philipp Csomor et al. · Kidney Medicine Open access 20 Nov 2020 167
26 Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP) Christian Breymann, Nils Thorm Milman, Anna Mezzacasa et al. · Journal of Perinatal Medicine Open access 8 Jun 2016 164
27 A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections Hartwig Wilhelm Bauer, Schanaz Alloussi, Günther Egger et al. · European Urology 5 Jan 2005 164
28 Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human studyin vivo Dreher, Gabard, Schwindt et al. · British Journal of Dermatology Aug 1998 164
29 Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects Ann E. Bolton, Bin Peng, Martine Hubert et al. · Cancer Chemotherapy and Pharmacology 22 Jan 2004 162
30 Anemia and iron deficiency in gastrointestinal and liver conditions Jürgen M. Stein, Susan Jane Connor, Garth Virgin et al. · World Journal of Gastroenterology Open access 2016 158
31 Intravenous Ferric Carboxymaltose in Iron-Deficient Chronic Heart Failure Patients with and Without Anaemia: a Subanalysis of the FAIR-HF Trial Gerasimos S Filippatos, Dimitrios T. Farmakis, Josep Comín Colet et al. · European Journal of Heart Failure Open access 20 Jun 2013 157
32 Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study Julien Renard, Stefania Ballarini, Teresa Mascarenhas et al. · Infectious Diseases and Therapy Open access 17 Dec 2014 156
33 Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects Catherine Dutreix, Bin Peng, Guenther H. Mehring et al. · Cancer Chemotherapy and Pharmacology 7 May 2004 154
34 Synthesis, crystal structure, and chemical stability of the superconductor FeSe1−x Ekaterina V. Pomjakushina, K. Conder, Vladimir Pomjakushin et al. · Physical Review B Open access 30 Jul 2009 151
35 Skin Penetration and Sun Protection Factor of Five UV Filters: Effect of the Vehicle Eric Chatelain, Bernard Gabard, Christian Surber · Skin Pharmacology and Physiology 2003 151
36 Long-read based de novo assembly of low-complexity metagenome samples results in finished genomes and reveals insights into strain diversity and an active phage system Vincent Somerville, Stefanie Lutz, Michael Schmid et al. · BMC Microbiology Open access 25 Jun 2019 145
37 Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients Jürgen Floege, Adrian Constantin Covic, Markus Ketteler et al. · Nephrology Dialysis Transplantation Open access 16 Feb 2015 144
38 Host-associated genetic differentiation in Thrips tabaci (Insecta; Thysanoptera), as determined from mtDNA sequence data Patrick C. Brunner, Elisavet K. Chatzivassiliou, Nikolaos I. Katis et al. · Heredity Open access 7 Jul 2004 144
39 Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial Edgar Turner Overton, Jack T. Stapleton, Ian Frank et al. · Open Forum Infectious Diseases Open access 2015 143
40 Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy Valery I. Radchenko et al. · Journal of Nuclear Medicine Open access 22 Jul 2021 136
41 Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis Piotr P. Ponikowski, Robert John Mentz, Adrian F. Hernandez et al. · European Heart Journal ReviewOpen access 24 Aug 2023 131
42 Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study Bernard Favrat, Katharina Balck, Christian Breymann et al. · PLoS ONE Open access 21 Apr 2014 130
43 In vitroactivity ofBacillus firmusagainst the burrowing nematodeRadopholus similis, the root-knot nematodeMeloidogyne incognitaand the stem nematodeDitylenchus dipsaci Alexander R. Mendoza, Sebastian Kiewnick, Richard Alexander Sikora · Biocontrol Science and Technology 2008 125
44 A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE® Alfred von Krempelhuber, Jens Vollmar, Rolf Pokorny et al. · Vaccine Open access 27 Nov 2009 124
45 Placebo-Controlled, Double-Blind, Randomized, Prospective Study of a Glycerol-Based Emollient on Eczematous Skin in Atopic Dermatitis: Biophysical and Clinical Evaluation Maria Breternitz, Doreen Kowatzki, Marcel Langenauer et al. · Skin Pharmacology and Physiology 16 Nov 2007 122
46 How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider Huub Schellekens, Sven Stegemann, Vera Weinstein et al. · The AAPS Journal Open access 25 Sep 2013 121
47 Rationale and Design of Ferinject® Assessment in Patients with IRon Deficiency and Chronic Heart Failure (FAIR-HF) Study: A Randomized, Placebo-Controlled Study of Intravenous Iron Supplementation in Patients with and without Anaemia Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al. · European Journal of Heart Failure Open access 29 Oct 2009 120
48 Minimal Clinically Important Difference in Quality of Life Scores for Patients with Heart Failure and Reduced Ejection Fraction Javed Butler, Muhammad Shahzeb Khan, Claudio Maria Mori et al. · European Journal of Heart Failure Open access 2 Apr 2020 118
49 Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl Isabel Diaz del Consuelo, Françoise Falson, Richard H. Guy et al. · Journal of Controlled Release 25 May 2007 118
50 Measurement of the Z13 contribution to the stopping power using MeV protons and antiprotons: The Barkas effect Lars H. Andersen, Preben Hvelplund, Helge V. Knudsen et al. · Physical Review Letters Open access 10 Apr 1989 117

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.